Sara Tolaney

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2024
September 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  

Sara Tolaney
Sep 10, 2024, 10:45 | Blog
Sara Tolaney: Mark your calendars for PER’s School of Breast Oncology
Sara Tolaney shared a post on X: “Mark your calendars for PER’s School of Breast…
Sep 7, 2024, 19:36 | Insight
A year of treatment with an ADC has proven highly effective in preventing stage 1 HER2-positive breast cancer from recurring - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared the following on LinkedIn: “A year of treatment with a medicine…
Sep 6, 2024, 11:25 | Insight
Paolo Tarantino: Interesting RWA of outcomes with chemotherapy in HR+/HER2- MBC
Paolo Tarantino shared a post by ESMO Open on X, adding: "Interesting real world analysis…
Sep 1, 2024, 15:26 | Insight
Guillermo Villacampa: Meta-analysis evaluating immunotherapy in early breast cancer
Recently, an article by Guillermo Villacampa et al. was published in JAMA Oncology. "Neoadjuvant Immune…
Jul 26, 2024, 00:18 | Blog
Sara Tolaney on novel therapies for young women with breast cancer at Young Women's Forum
Young Women's Forum shared on X: "Honored to have Sara Tolaney, Chief of Breast Oncology…
Jul 25, 2024, 08:58 | Insight
Marleen Kok: How do we get from one-size-fits-all to personalized treatment for TNBC
Marleen Kok, Breast Medical Oncologist at the Netherlands Cancer Institute, shared on X: "Today from…
Jul 14, 2024, 21:42 | Blog
Paolo Tarantino: Stellar Tumor Board session at the Harvard Medical School Breast Course
Paolo Tarantino shared a post on X: ''Stellar Tumor Board session at the Harvard Medical…
Jul 12, 2024, 20:47 | Societies
Stuart Schnitt on the future of breast pathology with the potential benefits of AI
Sara Tolaney shared on X: "Dr Stuart Schnitt does an outstanding job highlighting the future…
Jul 5, 2024, 05:41 | Blog
Abeid Athman: Joining ASCO had a huge role in shaping my career
Abeid Athman, Clinical Oncologist at Kenyatta University Hospital, shared on X: "It has been 5…
Jul 3, 2024, 22:59 | Blog
Aleix Prat: Our 2 articles published this week
Aleix Prat, Head of the Medical Oncology Department at Hospital Clínic Barcelona, shared on X:…
Jul 3, 2024, 10:44 | Blog
Abeid M. Athman Omar: The last four months have been very eventful for me
Abeid M. Athman Omar, Clinical Oncology Specialist at Kenyatta University, shared a post on LinkedIn: "The last…
Jul 3, 2024, 01:24 | Blog
Paolo Tarantino: ATEMPT would have not been possible without the vision of Sara Tolaney
Sara Tolaney shared a post by Paolo Tarantino on X: “Very lucky to get to…
Jul 2, 2024, 10:32 | Insight
Trastuzumab emtansine (T-DM1) is highly effective in preventing stage 1 HER2-positive breast cancer from recurring - MedEdge MEA
MedEdge MEA shared a post on LinkedIn:  . "A year of treatment with a medicine…
Jul 1, 2024, 15:23 | Insight
Paolo Tarantino: Final analysis of the ATEMPT phase 2 trial
Paolo Tarantino shared a post on X: “Can ADCs help prevent recurrence from breast cancer…
Jun 26, 2024, 03:41 | Insight
Paolo Tarantino: Opportunities to improve outcomes for early recurrent TNBC
Paolo Tarantino shared a post on X:         .  "Early recurrent TNBC (Triple-Negative…
Jun 22, 2024, 04:43 | Blog
Sara Tolaney: Please consider attending the School of Breast Oncology
Hope Rugo, Medical hematologist-oncologist at UCSF, shared a post by Sara Tolaney, on X: ''It is indeed.…
Jun 11, 2024, 15:21 | Blog
Abeid M. Athman Omar: Delighted to have received two awards at the ASCO24 meeting
Abeid M. Athman Omar, Clinical Oncology Specialist at Kenyatta University, shared a post on LinkedIn: ''I am…
May 31, 2024, 18:51 | Blog
Sameh Abdelmalak: Dr. Sara Tolaney and Dr. Hope Rugo discussing ASCO24 Noteworthy Abstracts in Breast Cancer
Sameh Abdelmalak, Director, Oncology, Educational Partnerships at VuMedi, made the following post on X: "Check…
May 22, 2024, 08:48 | Blog
SITC will host the free Summit on Immunomodulation of ADCs
Society for Immunotherapy of Cancer shared a post on X: “SITC will host the free Summit…
May 20, 2024, 13:16 | Career
Sara Tolaney is appointed as Alliance for Clinical Trials in Oncology Breast Committee Vice-Chair
Alliance for Clinical Trials in Oncology recently shared on X: "Congratulations to Sara Tolaney, MD,…
May 18, 2024, 10:02 | Societies
Matteo Lambertini: What a big honor to have Sara Tolaney at our ESMOYOC session
Matteo Lambertini, Medical Oncologist at San Martino, shared on X: . "What a big honor…
May 18, 2024, 09:54 | Societies
Paolo Tarantino: Why was IMpassion132 negative?
Daniel Stover, Medical Oncologist and Computational Biologist at Ohio State University Comprehensive Cancer Center, shared…
May 18, 2024, 08:12 | Blog
Paolo Tarantino: Sara Tolaney recapitulating 10+ years of de-escalation trials
Paolo Tarantino shared a post on X/Twitter: ''Terrific presentation by Sara Tolaney at ESMO Breast24, recapitulating…
May 18, 2024, 04:17 | Blog
Sara Tolaney: Interesting data from Mafalda Oliveira from SERENA-2 at ESMO Breast24
Sara Tolaney shared a post on X: ''Interesting data from Mafalda Oliveira from SERENA-2 demonstrating…
May 17, 2024, 11:41 | Insight
Sara Tolaney: Helpful discussion by Cristina Saura on how to think about adjuvant therapies in patients with gBRCAm
Sara Tolaney shared a post on X: “Very helpful discussion by Cristina Saura on how…
May 14, 2024, 16:00 | Blog
Dr. Sara Tolaney will be the invited discussant for three excellent Breast Cancer trials at ESMO Breast 24 - Dana Farber’s Breast Oncology Center
Dana Farber’s Breast Oncology Center shared a post on X: “Check out the ESMO Breast 24…
May 7, 2024, 11:51 | Positive
Sara Tolaney: HAPPY NURSES WEEK!
Sara Tolaney shared a post on X: "HAPPY NURSES WEEK! A special thank you to…
May 7, 2024, 03:53 | Blog
Aleix Prat: Dr. Tomás Pascual, will be co-presenting an educational talk alongside Sara Tolaney and Tatiana Prowell
Aleix Prat, Director of the Oncology Institute at Hospital Clínic Barcelona, shared a post on X:…
May 5, 2024, 06:21 | Blog
Sara Tolaney discussed the new breast cancer screening guidelines - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared on their X/Twitter: ''Sara Tolaney discussed the new breast cancer…
May 1, 2024, 13:41 | Opinion
Sara Tolaney: Such an important question addressed in the Alliance A011502 study
Sara Tolaney shared a post by Erman Akkus, Medical Oncology Fellow at Ankara University, on X/Twitter: "Such…
Apr 22, 2024, 11:40 | Blog
Sara Tolaney: Very excited to have Aleix Prat as the Schlager Lecturer at the Harvard Breast Course in July!
Sara Tolaney shared a post by Aleix Prat, Co-Founder of Reveal Genomics, on X/Twitter, adding:…
Mar 24, 2024, 08:23 | Drugs
Paolo Tarantino: Adding palbociclib to fulvestrant did not improve PFS in the PACE randomized phase 2 trial
Paolo Tarantino, Medical Oncologist and Research Fellow at Dana-Farber Cancer Institute, shared a post on…
Feb 27, 2024, 15:28 | Blog
Dr. Sara Tolaney discusses Antibody Drug Conjugates - Dana-Farber’s Breast Oncology Center
Quoting Dana-Farber’s Breast Oncology Center on X/Twitter: "Dr. Sara Tolaney discusses Antibody Drug Conjugates in…
Feb 14, 2024, 13:13 | Blog
Chiara Corti: Thanks so much to Gianni Bonadonna Foundation and AIRC Foundation for cancer research for this opportunity
Chiara Corti, Research Fellow at Dana-Farber Cancer Institute, shared a post by Gianni Bonadonna Foundation…
Dec 17, 2023, 17:26 | Blog
25 Posts Not To Miss From SABCS 2023
The San Antonio Breast Cancer Symposium 2023 (SABCS 2023) took place in San Antonio, Texas…
Dec 8, 2023, 17:54 | Career
Dana-Farber News congratulates Sara Tolaney on receiving the Susan G. Komen 2023 Rising Star Researcher Award
Dana-Farber News /Dana Farber Cancer Institute/ shared on their X/Twitter account: "Congrats to Dana-Farber Cancer…
Nov 1, 2023, 18:54 | Societies
20 Posts Not To Miss From ESMO 2023 Congress
The Annual Congress of the European Society For Medical Oncology (ESMO) took place from October…
Oct 21, 2023, 21:40 | Positive
100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2023: Part 9
We continue OncoDaily’s ‘100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social…
Oct 13, 2023, 17:39 | Blog
Sara Tolaney: Consider applying to the Gilead Research Scholars program if you are a junior faculty member looking for funding for research in solid tumors!
Quoting Sara Tolaney, Chief of the Division of Breast Oncology at Dana-Farber Cancer Institute, on…
Sep 15, 2023, 18:51 | Blog
Michail Ignatiadis: Join us tomorrow with ⁦Peter Fasching, Sara Tolaney and Stephen Johnston to discuss QoL in the phase 3 NATALEE trial of adjuvant ribociclib
Quoting Michail Ignatiadis, Director of Breast Medical Oncology Clinic & Program, Jules Bordet Institute, on…
Aug 25, 2023, 18:26 | Insight
Sara Tolaney: TROPICS-02 Overall Survival data now published in The Lancet!
Quoting Sara Tolaney, Chief of Division of Breast Oncology at Dana Farber Cancer Institute, on…
Aug 14, 2023, 17:39 | Insight
Check out the new review just published in Cancers MDPI on Tumor Mutational Burden in Breast Cancer - Dana-Farber’s Breast Oncology Center
Quoting from a recent tweet by Dana-Farber’s Breast Oncology Center: "Check out the new review…
All: 42 Posts: 1 - 100
Special Coverage